Significant disruptions can impact companies of any size in any industry due to COVID-19 outbreaks. Implementing the right COVID-19 testing protocols can lead to:
We are here to help you incorporate a COVID-19 testing plan that works for your individual situation
PCR testing for COVID-19 anytime, anywhere
SQI Diagnostics is the exclusive Canadian distributor of Biomeme’s Health Canada authorized, portable SARS-CoV-2 real-time PCR test, providing rapid, point-of-need testing in clinical, corporate and other settings. Our kits include everything you need to get from sample to result in about 90 minutes.
The test has been simplified to three steps through streamlined preparation processes that utilize pre-aliquoted and lyophilized reagents. Tests are run on the Biomeme Franklin Three9 thermocycler which is a lightweight and portable device with up to five hours of battery life, allowing for either centralized or remote testing.
This solution delivers sample to result in approximately 90 minutes with a throughput of 9 tests per one-hour thermocycler run. Results are displayed on an accompanying smart phone and can be managed through a cloud-based management system.
The Biomeme SARS-CoV-2 test detects the all the current variants of concern, including Alpha, Beta, Gamma, Epsilon, Delta and Omicron.
The Sofia® SARS Antigen Fluorescent Immunoassay (FIA) by Quidel uses advanced lateral flow technology to provide accurate results for the detection of SARS-CoV-2. The Sofia SARS Antigen FIA, with the Sofia 2 analyzer, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments. The test is Health Canada-approved for symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially. It can be utilized in innovative “read now” and “walk away” modes allowing up to 50 tests run per hour per device.
The Quidel Sofia® SARS Antigen FIA detects the all the current variants of concern, including Alpha, Beta, Gamma, Epsilon, Delta and Omicron.
The Sofia 2 Flu + SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. The Sofia 2 Flu + SARS Antigen FIA with the Sofia 2 analyzer provides automated and objective results in 15 minutes, allowing for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.
The QuickVue At-Home OTC COVID-19 Test lets you get rapid results, in the privacy of your own home, with everything you need included in the package. It is intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two to three days with at least 24 hours and no more than 36 hours between tests.
The SQI Diagnostic EXACT COVID-19 Antibody Test is the next generation of COVID-19 diagnostic tool, measuring antibody levels arising from vaccination and infection.
© 2024 SQI Diagnostics
